Soft-sensor model development for CHO growth/production, intracellular metabolite, and glycan predictions

Front Mol Biosci. 2024 Oct 22:11:1441885. doi: 10.3389/fmolb.2024.1441885. eCollection 2024.

Abstract

Efficaciously assessing product quality remains time- and resource-intensive. Online Process Analytical Technologies (PATs), encompassing real-time monitoring tools and soft-sensor models, are indispensable for understanding process effects and real-time product quality. This research study evaluated three modeling approaches for predicting CHO cell growth and production, metabolites (extracellular, nucleotide sugar donors (NSD) and glycan profiles): Mechanistic based on first principle Michaelis-Menten kinetics (MMK), data-driven orthogonal partial least square (OPLS) and neural network machine learning (NN). Our experimental design involved galactose-fed batch cultures. MMK excelled in predicting growth and production, demonstrating its reliability in these aspects and reducing the data burden by requiring fewer inputs. However, it was less precise in simulating glycan profiles and intracellular metabolite trends. In contrast, NN and OPLS performed better for predicting precise glycan compositions but displayed shortcomings in accurately predicting growth and production. We utilized time in the training set to address NN and OPLS extrapolation challenges. OPLS and NN models demanded more extensive inputs with similar intracellular metabolite trend prediction. However, there was a significant reduction in time required to develop these two models. The guidance presented here can provide valuable insight into rapid development and application of soft-sensor models with PATs for ipurposes. Therefore, we examined three model typesmproving real-time product CHO therapeutic product quality. Coupled with emerging -omics technologies, NN and OPLS will benefit from massive data availability, and we foresee more robust prediction models that can be advantageous to kinetic or partial-kinetic (hybrid) models.

Keywords: Michaelis-Menten; datadriven; fed-batch bioprocess; glycosylation; machine learning; monod kinetics.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded and supported by Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) through the industry–University Cooperative Research Center Program under U.S. National Science Foundation (Grant number: 1624684). This work was partially funded by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL, Grant/Award Number: 70NANB17H002).